Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - trimethoprim - oral tablet - 200mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - trimethoprim - oral tablet - 200mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

bryant ranch prepack - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

direct_rx - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

macleod pharmaceuticals inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 67 mg in 1 g

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

macleod pharmaceuticals inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 67 mg in 1 g

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - trimethoprim, quantity: 300 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate; magnesium stearate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. conditions varied as approved in the letter of 6 april 1992 from dr h. arora. indicated for the treatmenet of acute urinary tract infections caused by sensitive organisms.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - trimethoprim, quantity: 160 mg; sulfamethoxazole, quantity: 800 mg - tablet, uncoated - excipient ingredients: docusate sodium; sodium starch glycollate; povidone; magnesium stearate - indications as at 01 march 2002 : upper and lower respiratory tract infections; renal and urinary tract infections; genital tract infections; gastrointestinal tract infections; skin and wound infections; septicaemias, and other infections caused by sensitive organisms.

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadiazine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 80.0 mg/ml; sulfadiazine sulfanyl active 400.0 mg/ml - antibiotic & related - cattle | horse | pigs | sheep ewe - dry | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | co - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 20.0 mg/tb; sulfadiazine sulfanyl active 100.0 mg/tb - nutrition & metabolism - cat | dog - small or toy | cat - queen | cat - tom | dog - small | dog - toy | kitten - bacterial infection | infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | cystitis | gram negative organisms | gram positive organisms | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria